Share：
Share this content in WeChat
X
[Chinese][PDF]1011
• Review •
Current status and reseach progress of MRI diagnosis of endometriosis malignancy related to ovarian cancer
LIU Simeng  ZHAO Deli 

Cite this article as: LIU S M, ZHAO D L. Current status and reseach progress of MRI diagnosis of endometriosis malignancy related to ovarian cancer[J]. Chin J Magn Reson Imaging, 2024, 15(11): 221-226. DOI:10.12015/issn.1674-8034.2024.11.035.


[Abstract] Endometriosis (EMs) is a chronic pelvic disease that mainly occurs in women of childbearing age and can have a huge impact on women's daily quality of life. When malignant lesions occur in benign EMs lesions, ovarian cancer caused by malignant EMs is clinically referred to as endometriosis associated ovarian cancer (EAOC). Previous studies have not paid enough attention and recognization to the disease that " EMs deteriorates into EAOC". Therefore, how to systematically identify and diagnose this kind of disease through multimodal MRI has become an urgent problem to be solved in clinical practice. Effective early diagnosis can enable patients to get timely intervention treatment, which is crucial to improve the quality of life of patients. In this paper, the clinicopathological features and diagnosis status of these diseases will be introduced, and the characteristic manifestations and application value of different MRI techniques will be detailed, which will help to guide clinicians to diagnose and evaluate the malignant transformation from EMs to EAOC more reasonably and appropriately.
[Keywords] endometriosis；endometriosis associated ovarian cancer；malignant transformation；multimodal magnetic resonance imaging；summarize

LIU Simeng   ZHAO Deli*  

Imaging Center of the Sixth Affiliated Hospital of Harbin Medical University, Harbin150000, China

Corresponding author: ZHAO D L, E-mail: 5544783@qq.com

Conflicts of interest   None.

Received  2024-06-21
Accepted  2024-11-08
DOI: 10.12015/issn.1674-8034.2024.11.035
Cite this article as: LIU S M, ZHAO D L. Current status and reseach progress of MRI diagnosis of endometriosis malignancy related to ovarian cancer[J]. Chin J Magn Reson Imaging, 2024, 15(11): 221-226. DOI:10.12015/issn.1674-8034.2024.11.035.

[1]
HUBER M, GROSEL J, SHOWEN C. Recognizing abdominal wall endometriosis[J]. JAAPA, 2019, 32(7): 30-33. DOI: 10.1097/01.JAA.0000558237.67863.aa.
[2]
YE H, SHEN C Y, QUAN Q L, et al. Endometriosis of the skeletal muscular system (ESMS): a systematic review[J/OL]. BMC Womens Health, 2023, 23(1): 37 [2024-11-05]. https://pubmed.ncbi.nlm.nih.gov/36703173/. DOI: 10.1186/s12905-023-02184-8.
[3]
PEJOVIC T, THISTED S, WHITE M, et al. Endometriosis and endometriosis-associated ovarian cancer (EAOC)[J]. 2020, 1242: 73-87. DOI: 10.1007/978-3-030-38474-6_5
[4]
RADZYNSKI L, BOYER L, KOSSAI M, et al. Pictorial essay: MRI evaluation of endometriosis-associated neoplasms[J/OL]. Insights Imaging, 2023, 14(1): 144 [2024-11-05]. https://pubmed.ncbi.nlm.nih.gov/37673827/. DOI: 10.1186/s13244-023-01485-8.
[5]
THROWBA H P K, UNNIKRISHNAN L, PANGATH M, et al. The epigenetic correlation among ovarian cancer, endometriosis and PCOS: A review[J/OL]. Crit Rev Oncol Hematol, 2022, 180: 103852 [2024-11-05]. https://pubmed.ncbi.nlm.nih.gov/36283585/. DOI: 10.1016/j.critrevonc.2022.103852.
[6]
TANASE Y, KAWAGUCHI R, TAKAHAMA J, et al. Factors that differentiate between endometriosis-associated ovarian cancer and benign ovarian endometriosis with mural nodules[J]. Magn Reson Med Sci, 2018, 17(3): 231-237. DOI: 10.2463/mrms.mp.2016-0149.
[7]
MACIEL C, FERREIRA H, DJOKOVIC D, et al. MRI of endometriosis in correlation with the #Enzian classification: applicability and structured report[J/OL]. Insights Imaging, 2023, 14(1): 120 [2024-11-05]. https://pubmed.ncbi.nlm.nih.gov/37405519/. DOI: 10.1186/s13244-023-01466-x.
[8]
FOTI P V, FARINA R, PALMUCCI S, et al. Endometriosis: clinical features, MR imaging findings and pathologic correlation[J]. Insights Imaging, 2018, 9(2): 149-172. DOI: 10.1007/s13244-017-0591-0.
[9]
SAKALA M D, SHAMPAIN K L, WASNIK A P. Advances in MR imaging of the female pelvis[J]. Magn Reson Imaging Clin N Am, 2020, 28(3): 415-431. DOI: 10.1016/j.mric.2020.03.007.
[10]
LANG J H. Endometriosis and tumor: also on the malignant transformation of endometriosis[J]. Chin J Obstet Gynecol, 2019, 54(9): 577-581. DOI: 10.3760/cma.j.issn.0529-567x.2019.09.001.
[11]
ZHOU L, YAO L Q, DAI L, et al. Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study[J/OL]. J Ovarian Res, 2021, 14(1): 63 [2024-11-05] https://pubmed.ncbi.nlm.nih.gov/33941230/. DOI: 10.1186/s13048-021-00804-1.
[12]
KAJIYAMA H, SUZUKI S, YOSHIHARA M, et al. Endometriosis and cancer[J]. Free Radic Biol Med, 2019, 133: 186–192. DOI: 10.1016/j.freeradbiomed.2018.12.015.
[13]
MATIAS-GUIU X, STEWART C J R. Endometriosis-associated ovarian neoplasia[J]. Pathology, 2018, 50(2): 190-204. DOI: 10.1016/j.pathol.2017.10.006.
[14]
MCCALLION A, NASIRZADEH Y, LINGEGOWDA H, et al. Estrogen mediates inflammatory role of mast cells in endometriosis pathophysiology[J/OL]. Front Immunol, 2022, 13: 961599 [2024-11-05]. https://pubmed.ncbi.nlm.nih.gov/36016927/. DOI: 10.3389/fimmu.2022.961599.
[15]
ABRAMIUK M, GRYWALSKA E, MAŁKOWSKA P, et al. The role of the immune system in the development of endometriosis[J/OL]. Cells, 2022, 11(13): 2028 [2024-11-05]. https://pubmed.ncbi.nlm.nih.gov/35805112/. DOI: 10.3390/cells11132028.
[16]
GURALP O, KAYA B, TÜTEN N, et al. Non-invasive diagnosis of endometriosis and moderate-severe endometriosis with serum CA125, endocan, YKL-40, and copeptin quadruple panel[J]. J Obstet Gynaecol, 2021, 41(6): 927-932. DOI: 10.1080/01443615.2020.1803245.
[17]
BAZOT M, BHARWANI N, HUCHON C, et al. European society of urogenital radiology (ESUR) guidelines: MR imaging of pelvic endometriosis[J]. Eur Radiol, 2017, 27(7): 2765-2775. DOI: 10.1007/s00330-016-4673-z.
[18]
RUAUX E, NOUGARET S, GAVREL M, et al. Endometriosis MR mimickers: T1-hyperintense lesions[J/OL]. Insights Imaging, 2024, 15(1): 19 [2024-11-05]. https://pubmed.ncbi.nlm.nih.gov/38267748/. DOI: 10.1186/s13244-023-01587-3.
[19]
CANSU A, BULUT E, DINC G, et al. Diagnostic efficacy of T2 dark spot, T2 dark rim signs, and T2 shading on magnetic resonance imaging in differentiating endometriomas from hemorrhagic cysts[J]. J Comput Assist Tomogr, 2019, 43(4): 619-622. DOI: 10.1097/RCT.0000000000000892.
[20]
SAKALA M D, JHA P, TONG A, et al. MR imaging of endometriosis of the adnexa[J]. Magn Reson Imaging Clin N Am, 2023, 31(1): 121-135. DOI: 10.1016/j.mric.2022.06.006.
[21]
KIDO A, HIMOTO Y, MORIBATA Y, et al. MRI in the diagnosis of endometriosis and related diseases[J]. Korean J Radiol, 2022, 23(4): 426-445. DOI: 10.3348/kjr.2021.0405.
[22]
ROBINSON K A, MENIAS C O, CHEN L W, et al. Understanding malignant transformation of endometriosis: imaging features with pathologic correlation[J]. Abdom Radiol (NY), 2020, 45(6): 1762-1775. DOI: 10.1007/s00261-019-01914-7.
[23]
NISHIO N, KIDO A, KATAOKA M, et al. Longitudinal changes in magnetic resonance imaging of malignant and borderline tumors associated with ovarian endometriotic cyst comparing with endometriotic cysts without arising malignancy[J]. Eur J Radiol, 2018, 105: 175-181. DOI: 10.1016/j.ejrad.2018.06.007.
[24]
WANG J D, QU Q X, ZHANG S Q. Diagnosis and treatment of endometriosis-related ovarian cancer expert consensus in Shandong (2022)[J]. Shandong Med J, 2022, 62(18): 1-6. DOI: 10.3969/j.issn.1002-266X.2022.18.001.
[25]
BONDE A, LAGO E A D, FOSTER B, et al. Utility of the diffusion weighted sequence in gynecological imaging: review article[J/OL]. Cancers, 2022, 14(18): 4468 [2024-11-05]. https://pubmed.ncbi.nlm.nih.gov/36139628/. DOI: 10.3390/cancers14184468.
[26]
TAKEUCHI M, MATSUZAKI K, BANDO Y, et al. Magnetic resonance imaging characteristics of polypoid endometriosis and review of the literature[J]. J Obstet Gynaecol Res, 2022, 48(10): 2583-2593. DOI: 10.1111/jog.15367.
[27]
TÜRKOĞLU S, KAYAN M. Differentiation between benign and malignant ovarian masses using multiparametric MRI[J]. Diagn Interv Imaging, 2020, 101(3): 147-155. DOI: 10.1016/j.diii.2020.01.006.
[28]
GITY M, PARVIZ S, RAD H S, et al. Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): quantitative and Semi-quantitative analysis at 3-Tesla MRI[J]. Asian Pac J Cancer Prev, 2019, 20(4): 1073-1079. DOI: 10.31557/APJCP.2019.20.4.1073.
[29]
OHYA A, FUJINAGA Y. Magnetic resonance imaging findings of cystic ovarian tumors: major differential diagnoses in five types frequently encountered in daily clinical practice[J]. Jpn J Radiol, 2022, 40(12): 1213-1234. DOI: 10.1007/s11604-022-01321-x.
[30]
GHAFOOR S, LAKHMAN Y, PARK K J, et al. Polypoid endometriosis: a mimic of malignancy[J]. Abdom Radiol (NY), 2020, 45(6): 1776-1782. DOI: 10.1007/s00261-019-02143-8.
[31]
CHEN C H. Decidualized ovarian endometrioma[J/OL]. Am J Obstet Gynecol, 2022, 226(4): 567 [2024-11-05]. https://pubmed.ncbi.nlm.nih.gov/34627779/. DOI: 10.1016/j.ajog.2021.10.002.
[32]
HARAGUCHI T, KOBAYASHI Y, HIRAHARA D, et al. Radiomics model of diffusion-weighted whole-body imaging with background signal suppression (DWIBS) for predicting axillary lymph node status in breast cancer[J]. J Xray Sci Technol, 2023, 31(3): 627-640. DOI: 10.3233/XST-230009.
[33]
RIZZO S, PIANO F D, BUSCARINO V, et al. Pre-operative evaluation of epithelial ovarian cancer patients: role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study[J/OL]. Eur J Radiol, 2020, 123: 108786 [2024-11-05]. https://pubmed.ncbi.nlm.nih.gov/31862634/. DOI: 10.1016/j.ejrad.2019.108786.
[34]
MANGANARO L, PORPORA M G, VINCI V, et al. Diffusion tensor imaging and tractography to evaluate sacral nerve root abnormalities in endometriosis-related pain: a pilot study[J]. Eur Radiol, 2014, 24(1): 95-101. DOI: 10.1007/s00330-013-2981-0.
[35]
ONBAS O, KANTARCI M, ALPER F, et al. Nodular endometriosis: dynamic MR imaging[J]. Abdom Imaging, 2007, 32(4): 451-456. DOI: 10.1007/s00261-006-9038-7.
[36]
GHASSABAN K, LIU S F, JIANG C H, et al. Quantifying iron content in magnetic resonance imaging[J]. NeuroImage, 2019, 187: 77-92. DOI: 10.1016/j.neuroimage.2018.04.047.
[37]
DUSEK P, LESCINSKIJ A, RUZICKA F, et al. Associations of brain atrophy and cerebral iron accumulation at MRI with clinical severity in Wilson disease[J]. Radiology, 2021, 299(3): 662-672. DOI: 10.1148/radiol.2021202846.
[38]
MELONI A, PISTOIA L, RESTAINO G, et al. Quantitative T2* MRI for bone marrow iron overload: normal reference values and assessment in thalassemia major patients[J]. Radiol Med, 2022, 127(11): 1199-1208. DOI: 10.1007/s11547-022-01554-w.
[39]
KOBAYASHI H, YAMADA Y, KAWAHARA N, et al. Modern approaches to noninvasive diagnosis of malignant transformation of endometriosis[J]. Oncol Lett, 2019, 17(1): 1196-1202. DOI: 10.3892/ol.2018.9721.
[40]
YOSHIMOTO C, TAKAHAMA J, IWABUCHI T, et al. Transverse relaxation rate of cyst fluid can predict malignant transformation of ovarian endometriosis[J]. Magn Reson Med Sci, 2017, 16(2): 137-145. DOI: 10.2463/mrms.mp.2016-0028.
[41]
YAN S M, DONG X Y, DING D W, et al. Iron deposition in ovarian endometriosis evaluated by magnetic resonance imaging R2* correlates with ovarian function[J/OL]. Reprod Biomed Online, 2023, 47(3): 103231 [2024-11-05]. https://pubmed.ncbi.nlm.nih.gov/37385897/. DOI: 10.1016/j.rbmo.2023.05.003.
[42]
LIU M N, CHEN L, XU T M, et al. Potential clinical implications of iron metabolism in ovarian endometriosis[J/OL]. J Trace Elem Med Biol, 2022, 73: 127017 [2024-11-05]. https://pubmed.ncbi.nlm.nih.gov/35763972/. DOI: 10.1016/j.jtemb.2022.127017.
[43]
ANSARINIYA H, YAVARI A, JAVAHERI A, et al. Oxidative stress-related effects on various aspects of endometriosis[J/OL]. Am J Reprod Immunol, 2022, 88(3): e13593 [2024-11-05]. https://pubmed.ncbi.nlm.nih.gov/35781369/. DOI: 10.1111/aji.13593.
[44]
KANG W D, QIU X, LUO Y G, et al. Application of radiomics-based multiomics combinations in the tumor microenvironment and cancer prognosis[J/OL]. J Transl Med, 2023, 21(1): 598 [2024-11-05]. https://pubmed.ncbi.nlm.nih.gov/37674169/. DOI: 10.1186/s12967-023-04437-4.
[45]
SHRESTHA P, POUDYAL B, YADOLLAHI S, et al. A systematic review on the use of artificial intelligence in gynecologic imaging - Background, state of the art, and future directions[J]. Gynecol Oncol, 2022, 166(3): 596-605. DOI: 10.1016/j.ygyno.2022.07.024.
[46]
LIU X F, WANG T P, ZHANG G F, et al. Two-dimensional and three-dimensional T2 weighted imaging-based radiomic signatures for the preoperative discrimination of ovarian borderline tumors and malignant tumors[J/OL]. J Ovarian Res, 2022, 15(1): 22 [2024-11-05]. https://pubmed.ncbi.nlm.nih.gov/35115022/. DOI: 10.1186/s13048-022-00943-z.
[47]
SONG X L, REN J L, ZHAO D, et al. Radiomics derived from dynamic contrast-enhanced MRI pharmacokinetic protocol features: the value of precision diagnosis ovarian neoplasms[J]. Eur Radiol, 2021, 31(1): 368-378. DOI: 10.1007/s00330-020-07112-0.

PREV Research process in imaging prediction of post-hepatectomy liver failure
NEXT Potential of the nuclear overhauser effect in precision medicine: From basic research to clinical applications
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn